These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 15290453)
21. New and emerging treatment of Staphylococcus aureus infections in the hospital setting. Moreillon P Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():32-41. PubMed ID: 18318877 [TBL] [Abstract][Full Text] [Related]
22. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849 [TBL] [Abstract][Full Text] [Related]
23. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains]. Efe S; Sinirtaş M; Ozakin C Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917 [TBL] [Abstract][Full Text] [Related]
24. Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Poon H; Chang MH; Fung HB Clin Ther; 2012 Apr; 34(4):743-65. PubMed ID: 22444785 [TBL] [Abstract][Full Text] [Related]
25. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci]. Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M; Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529 [TBL] [Abstract][Full Text] [Related]
26. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents]. Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259 [TBL] [Abstract][Full Text] [Related]
27. In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China. Wang H; Liu Y; Sun H; Xu Y; Xie X; Chen M Diagn Microbiol Infect Dis; 2008 Oct; 62(2):226-9. PubMed ID: 18653301 [TBL] [Abstract][Full Text] [Related]
28. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Nomura S; Hanaki H; Unemi N Chemotherapy; 1996; 42(4):253-8. PubMed ID: 8804792 [TBL] [Abstract][Full Text] [Related]
29. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus. Scheinfeld N J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167 [TBL] [Abstract][Full Text] [Related]
30. In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria. Chamberland S; Blais J; Hoang M; Dinh C; Cotter D; Bond E; Gannon C; Park C; Malouin F; Dudley MN Antimicrob Agents Chemother; 2001 May; 45(5):1422-30. PubMed ID: 11302805 [TBL] [Abstract][Full Text] [Related]
31. [Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro]. Kouda M; Homma S; Udagawa I; Fukuhara J; Takeuchi M; Tamura K Jpn J Antibiot; 2000 Mar; 53(3):171-8. PubMed ID: 10834148 [TBL] [Abstract][Full Text] [Related]
32. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus. Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411 [TBL] [Abstract][Full Text] [Related]
33. In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates. Vidaillac C; Leonard SN; Rybak MJ Int J Antimicrob Agents; 2010 Jun; 35(6):527-30. PubMed ID: 20346632 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus. Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; Pichardo C; Ibáñez-Martínez J; Pachón J J Antimicrob Chemother; 2012 Aug; 67(8):1961-7. PubMed ID: 22532466 [TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil. Kuti JL; Kiffer CR; Mendes CM; Nicolau DP Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672 [TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus. Jacqueline C; Navas D; Batard E; Miegeville AF; Le Mabecque V; Kergueris MF; Bugnon D; Potel G; Caillon J Antimicrob Agents Chemother; 2005 Jan; 49(1):45-51. PubMed ID: 15616274 [TBL] [Abstract][Full Text] [Related]
37. Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models. Patel MV; De Souza NJ; Gupte SV; Jafri MA; Bhagwat SS; Chugh Y; Khorakiwala HF; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 2004 Dec; 48(12):4754-61. PubMed ID: 15561853 [TBL] [Abstract][Full Text] [Related]
38. Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers. Sader HS; Farrell DJ; Flamm RK; Jones RN Surg Infect (Larchmt); 2016 Aug; 17(4):443-7. PubMed ID: 26990170 [TBL] [Abstract][Full Text] [Related]
39. In vitro activity of ceftobiprole on 440 Staphylococcus aureus strains isolated from bronchopulmonary infections. Hodille E; Delouere L; Bouveyron C; Meugnier H; Bes M; Tristan A; Laurent F; Vandenesch F; Lina G; Dumitrescu O Med Mal Infect; 2017 Mar; 47(2):152-157. PubMed ID: 27856079 [TBL] [Abstract][Full Text] [Related]
40. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study. Wang Z; Cao B; Liu YM; Gu L; Wang C Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]